According to Futurewise analysis, the C-reactive protein (CRP) assays for research use only (RUO) and the IVD market in 2024 were US$990.69 million and are expected to grow at a CAGR of 5% by 2032. The market is expanding primarily due to the increasing prevalence of cardiovascular diseases and inflammatory conditions worldwide. These health issues require accurate biomarker tests for diagnosis and monitoring. Additionally, the rise in point-of-care testing devices and automated laboratory instruments is contributing to market growth. There is also a growing awareness of preventive healthcare, leading to the inclusion of C-reactive protein (CRP) testing in regular health screenings. This trend helps maintain steady demand for both clinical and research applications. C-reactive protein (CRP) assays are laboratory tests designed to measure the levels of CRP, a substance produced by the liver during inflammation. CRP acts as a biomarker indicating the presence of inflammation in the body. Levels of CRP can increase due to various health issues, including infections, chronic diseases, and inflammatory conditions.

Innovative Technologies and Formats- Portable and Point-of-Care (POC) Devices: Fast, handheld CRP analyzers are becoming widely available, some delivering results in just a few minutes and even connecting to smartphones for easier monitoring.

Next-Generation ELISAs: High-sensitivity CRP kits now provide faster results, with many pre-coated or ready-to-use formats that reduce lab preparation time.

Nanotech & Biosensor Breakthroughs: Advanced biosensors, including plasmon-assisted and nanobody-modified platforms, enable highly sensitive and multiplexed CRP detection.

Market Growth- The global market for C-reactive protein (CRP) testing is undergoing significant growth, with projections indicating that it will reach a value of $5 to $6 billion by 2030. This expansion is primarily driven by the increasing trend of home testing, the ongoing need for monitoring chronic diseases, and the growing adoption of advanced immunoturbidimetric assays in clinical settings.

These assays are essential in both clinical and research settings. Clinically, they are used for diagnosing and monitoring conditions such as autoimmune diseases, infections, and other inflammatory disorders. Additionally, they help evaluate the effectiveness of treatments aimed at reducing inflammation. In research, CRP assays contribute to studies investigating the connections between inflammation and various diseases, improving our understanding of inflammatory processes in the body and potential therapeutic interventions. Overall, monitoring CRP levels is a critical tool for assessing a patient’s health and guiding treatment decisions.

FutureWise Market Research has instantiated a report that provides an intricate analysis of C-Reactive Protein (CRP) Assays for Research Use Only (RUO) and IVD Market trends that shall affect the overall market growth.

Request a Free Sample @

https://www.futurewiseresearch.com/contact.aspx?rpt=15651&type=requestsample

By Type

• High Sensitivity C-Reactive Protein (hs-CRP) Assay
• Standard/Conventional CRP Assays

By Assays Type

• ELISA
• Immunoturbidimetric Assay
• Chemiluminescence Immunoassay
• Others

By Application

• Research Use (RUO)
• In-Vitro Diagnostics (IVD)

By End User

• Hospitals and laboratories
• Research and Academic Centers
• Clinic Research Organizations (CROs)
• Pharma and Biopharmaceutical companies
• Others

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape in C-Reactive Protein (CRP) Assays for Research Use Only (RUO) and IVD Market:

• Thermo Fisher Scientific Inc.
• Merck KGaA
• ALPCO
• ACROBiosystems
• EagleBio
• IBL America
• Diagnostics Biochem Canada Inc.
• Crystal Chem
• St John’s Laboratory Ltd
• LifeSpan Biosciences, Inc
• BD
• MP BIOMEDICALS
• F. Hoffmann-La Roche Ltd
• Siemens Healthineers 
• Abbott Laboratories
• Agilent Technologies
• Qiagen N.V.
• Randox Laboratories Ltd. 

Recent developments by key players in the C-Reactive Protein (CRP) Assays for Research Use Only (RUO) and IVD Market:

Thermo Fisher Scientific Inc.

• Product Launches: Thermo Fisher provides a variety of CRP ELISA kits, including high-sensitivity versions that are suitable for both research and clinical applications.
• Regulatory Compliance: The company is excitedly gearing up for the In Vitro Diagnostic Regulation (IVDR) in the European Union, confidently ensuring that our products exceed the new standards!

Merck KGaA

• Merck KGaA provides the C-Reactive Protein ELISA Kit, known as CYT298. This kit utilizes a double polyclonal antibody sandwich enzyme immunoassay, specifically designed for the quantitative measurement of C-Reactive Protein (CRP) levels in humans.

Siemens Healthineers 

• Product Offering: Siemens provides the Cardiophase hsCRP assay, a quantitative test for detecting very low levels of CRP in blood, aiding in cardiac risk assessment and prognostic evaluation of heart disease
• Platform Integration: The Atellica® Solution provides a comprehensive menu of over 210 assays, including CRP tests, designed for flexibility and efficiency in laboratory diagnostics.

Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=15651&license=multi

**Objectives of this Study: **

1. To provide a comprehensive analysis of the C-Reactive Protein (CRP) Assays for Research Use Only (RUO) and IVD Market By Type, By Assays Type, By Application, By End User and By Region.
2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

                                                                                                                
Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
• The customization services offered are free of charge with the purchase of any license of the report.
• You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com